US20020068922A1 - Method for intraluminally inducing cardioplegic arrest and catheter for use therein - Google Patents
Method for intraluminally inducing cardioplegic arrest and catheter for use therein Download PDFInfo
- Publication number
- US20020068922A1 US20020068922A1 US10/029,681 US2968101A US2002068922A1 US 20020068922 A1 US20020068922 A1 US 20020068922A1 US 2968101 A US2968101 A US 2968101A US 2002068922 A1 US2002068922 A1 US 2002068922A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- heart
- lumen
- pass
- balloon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
- A61B2018/00232—Balloons having an irregular shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
- A61B2018/0025—Multiple balloons
- A61B2018/00261—Multiple balloons arranged in a line
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/003—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
- A61M2025/0031—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves characterized by lumina for withdrawing or delivering, i.e. used for extracorporeal circuit treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/028—Holding devices, e.g. on the body having a mainly rigid support structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
- A61M2202/047—Liquids non-physiological cardioplegic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
- A61M2210/127—Aorta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/0032—Multi-lumen catheters with stationary elements characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts
Definitions
- the present invention relates to a method for inducing cardioplegic arrest in a heart and to catheters for use in that method.
- the present invention contemplates, at least in its preferred embodiments, the possibility of effective ascending aortic occlusion, cardioplegia, venting, right heart deflation and topical cooling in association with extracorporeal cardiopulmonary bypass all without necessitating a median sternotomy or other thoracic incision.
- the present invention consists in a method for inducing cardioplegic arrest of a heart in situ in a patient's body, comprising the steps of:
- the method according to the present invention may be carried out on humans or other mammalian animals.
- the method is of particular applicability in humans as it allows an alternative approach to open heart surgery and the development of closed cardioscopic surgery.
- the method according to the invention enables a percutaneous by-pass system to be associated with cardioplegia, venting and cooling of the heart which subverts the need for median stemotomy. This may, in turn, reduce the complications of the surgery.
- the maintenance of the systemic circulation involves establishing a cardiopulmonary by-pass.
- the blood may be drawn into the by-pass merely by positioning a percutaneous catheter into the right atrium and/or into one or both of the vena cavae through which venous blood may be drawn from the heart into an extracorporeal pump oxygenator.
- a single catheter with two inflatable cuffs, or two separate catheters, each with an inflatable cuff are introduced into the vena cavae to occlude them adjacent to their right atrial inlets. This allows isolation of the right atrium and allows blood to be drawn from the vena cavae into the by-pass system.
- This infusion has the advantage that it allows the heart to be cooled and improves visual acuity within the right heart allowing direct cardioscopic examination and/or intervention.
- the catheter used to decompress the right atrium and to draw blood into the by-pass is preferably introduced through the femoral vein by percutaneous puncture or direct cut down.
- catheters with inflatable cuffs as described above, are placed preferably such that in inflatable cuff of the cannula is positioned within each of the inferior (suprahepatic) and superior vena cavae.
- a separate lumen is preferably used to infuse saline between the two inflated cuffs into the right atrium.
- each of the inferior and superior vena cavae is preferably introduced percutaneously from the femoral vein and that for the superior vena cavae is introduced percutaneously through the jugular or subclavian vein.
- the ascending aorta is preferably occluded by a balloon catheter introduced percutaneously through the femoral artery.
- This catheter must carry adjacent its tip an inflatable cuff or balloon of sufficient size that upon being inflated it is able to completely occlude the ascending aorta.
- the length of the balloon should preferably not be so long as to impede the flow of blood or other solution to the coronary arteries or to the brachiocephalic, left carotid or left subclavian arteries.
- a balloon length of about 40 mm and diameter of about 35 mm is suitable in humans.
- the balloon is of a cylindrical shape to fully and evenly accommodate the lumen of the ascending aorta. This maximizes the surface area contact with the aorta, and allows for even distribution of occlusive pressure.
- the balloon of the catheter is preferably inflated with a saline solution to avoid the possibility of introducing into the patient an air embolism in the event that the balloon ruptured.
- the balloon should be inflated to a pressure sufficient to prevent regurgitation of blood into the aortic root and to prevent migration of the balloon into the root whilst not being so high as to cause damage or dilation to the aortic wall.
- An intermediate pressure of the order of 350 mmHg has been proven effective in trials.
- the aortic catheter is preferably introduced under fluoroscopic guidance over a suitable guidewire.
- Transoesophageal echocardiography can alternatively be used for positioning as has been described with reference to the venous catheter.
- the catheter may serve a number of separate functions and the number of lumina in the catheter will depend upon how many of those functions the catheter is to serve.
- the catheter can be used to introduce the cardioplegic agent, normally in solution, into the aortic root via one lumen.
- the luminal diameter will preferably be such that a flow of the order of 250-500 ml/min of cardioplegic solution can be introduced into the aortic root under positive pressure to perfuse adequately the heart by way of the coronary arteries.
- the same lumen can, by applying negative pressure to the lumen from an outside source, effectively vent the left heart of blood or other solutions. It may also be desirable to introduce medical instruments and/or a cardioscope into the heart through another lumen in the catheter.
- the lumen should be of a diameter suitable to pass a fibre-optic light camera of no greater than 3 mm diameter. It is however, preferable that the diameter and cross-sectional design of the internal lumina is such that the external diameter of the catheter in its entirety is small enough to allow its introduction into the adult femoral artery by either percutaneous puncture or direct cut-down
- the oxygenated blood returning to the body from the by-pass system may be conveyed into the aorta from another lumen in the cannula carrying the balloon.
- the returning blood is preferably discarded from the catheter in the external iliac artery.
- a separate arterial catheter of known type may be used to return blood to the patient from the by-pass system.
- a short catheter is positioned in the other femoral artery to provide systemic arterial blood from the by-pass system.
- the control end of the catheter i.e. that end that remains outside of the body, should have separate ports of attachment for the lumina.
- the catheter length should be approximately 900 mm for use in humans.
- the cardioplegic agent may be any of the known materials previously known to be useful, or in the future found to be useful, as cardiopiegic agents.
- the agent is preferably infused as a solution into the aortic root through one of the lumina of the aortic catheter.
- the present invention consists in a catheter for use in occluding the ascending aorta comprising an elongate tube having one or more continuous lumina along its length, an inflatable cuff is disposed about the tube adjacent one end thereof, the cuff being of such a size that upon being inflated it is able to occlude the ascending aorta of a patient.
- the catheter and method according to the present invention can be used to induce cardioplegic arrest and may be used in a number of surgical procedures. These include the following:
- Coronary artery revascularization such as:
- FIG. 1 is a schematic partly cut-away representation of a patient's heart having percutaneous catheters placed therein for carrying out the method according to the present invention:
- FIG. 2 is a similar view to FIG. 1 showing the aortic catheter in position but including an angioscope and a left ventricular venting cannula introduced into the aortic root and left ventricle respectively, via separate lumina within the aortic catheter:
- FIG. 3 is a front elevational view of part of the vascular system or a patient showing, inter alia, the aortic balloon catheter positioned in the ascending aorta via the femoral artery:
- FIG. 4 is a side elevational view of the control end of the aortic catheter according to the present invention:
- FIG. 5 is a partly cut away side elevational view of the balloon end of the catheter of FIG. 4 in an inflated condition:
- FIG. 6 a is a cross-sectional view of the catheter of FIG. 4 intermediate the control end and the balloon end;
- FIG. 6 b is an alternative cross-sectional arrangement of the lumina in the catheter of FIG. 4;
- FIG. 7 is a cross-sectional view through the balloon end of the catheter of FIG. 4;
- FIGS. 8 a and 8 b show schematically two alternative arrangements to the catheter shown in FIG. 4;
- FIGS. 9 a and 9 b show schematically two alternative catheter arrangements for the isolation of the right atrium and venous drainage.
- FIGS. 1 and 2 The heart 10 of FIGS. 1 and 2 is positioned in the living body of a patient and is accessed percutaneously.
- the catheter 11 is inserted through the femoral vein preferably.
- a suitable guide wire is initially inserted and the catheter 11 is then introduced in known manner under fluoroscopic guidance.
- the catheter 11 includes a pair of separately inflatable balloons 14 and 15 each connected to a balloon inflation control device (not shown) through suitable lumina in the catheter 11 .
- the balloon 14 is adapted to occlude the superior vena cavae 16 while the balloon 15 is adapted to occlude the suprahepatic inferior vena cavae 17 .
- a blood withdrawal lumen in the catheter 11 has an inlet orifice 18 flush with the balloon 14 , to avoid venous collapse during blood flow into the catheter 11 , and a series of inlet slots 19 in the inferior vena cavae. Blood drawn into the inlets 18 and 19 enters a common single lumen. Blood drawn into the by-pass system through the catheter 11 is oxygenated and returned to the patient in a manner which will be hereinafter described.
- a separate lumen in the catheter 11 opens into the right atrium 22 through aperture 21 to allow evacuation of blood from the right heart and the infusion of saline to induce topical cooling and/or to improve visual acuity within the right heart.
- the balloons may be inflated or deflated to vary the rate of venous return to the right atrium 22 and therefore the degree of decompression of the left heart.
- Venous drainage may be effected by gravitational drainage or by applying a degree of negative pressure to assist flow into the pump oxygenator. It will be appreciated that the distance between the balloons 14 and 15 will need to be correct for a given patient and this may be assessed by X-ray examination to allow selection of an appropriately sized catheter.
- separate catheters 11 b and 11 c could be used, as is shown in FIG. 9 a , for the inferior and superior vena cavae.
- the cannula 11 b being introduced as has been described above and the cannula 11 c being introduced through the jugular or subclavian vein. It will also be appreciated that for simple operations not requiring complete occlusion of the right atrium it is possible to merely insert a simple catheter 1 I into the right atrium to draw blood into the by-pass system as is seen in FIG. 2. Positioning under fluoroscopic guidance is not essential in this case.
- the catheter 12 is positioned in the manner described above with its free end located in the ascending aorta 23 .
- the catheter 12 is so positioned by insertion preferably through the femoral artery 24 and via the descending aorta 25 as is seen in FIG. 3.
- a fluoroscopic dye may be introduced into the aortic root 26 through the catheter 12 for accurate positioning of the tip of the catheter 12 relative to the aortic root 26 and the coronary ostia.
- the catheter 12 carries at its free end a balloon 27 .
- the balloon 27 is arranged to be inflated with saline from an inflation control device 28 of known type through a lumen in the catheter 12 .
- the device 28 is fitted with a pressure gauge 29 to allow the operator to control the inflation of the balloon 27 .
- the pressure of the fully inflated balloon 27 should be of the order of 350 mmHg so as to be sufficient to effectively occlude the aorta and to prevent the balloon moving while not being so great as to cause damage to the aortic wall.
- the balloon 27 should have a maximum diameter sufficient to occlude the aorta and for this purpose the maximum diameter should be about 35 mm.
- the balloon 27 should have a length of about 40 mm so as not to be so long as to occlude or impede blood flow to the coronary arteries or to the brachiocephalic, subclavian or carotid arteries. If necessary in any given patient the required length and diameter of the balloon may be determined by angiographic. X-ray examination or echocardiography and an appropriately sized catheter selected on that basis.
- the balloon 27 is preferably connected to the lumen 32 through which it is inflated at the end of the balloon 27 distal to the tip of the catheter 12 through orifice 31 (see FIG. 5). This allows the tip of the catheter to contain fewer lumina than the remainder of the catheter. Accommodation of the deflated balloon around the tip of the catheter is thus possible without adding to the diameter of the tip as compared with the rest of the catheter 12 .
- the catheter 12 includes a plurality of lumina (see FIGS. 6 and 7).
- the balloon inflation lumen 32 there is at least a single venting/cardioplegia lumen 33 of circular cross-section.
- the diameter of the various lumina should be as small as practicable commensurate with the intended use.
- the arterial return lumen 35 may comprise its own catheter 39 of known type introduced into the other femoral artery or some other suitable artery.
- the catheter 12 is introduced percutaneously by puncture or cutdown as has been described and once blood flow through the by-pass is established (including systemic cooling) flows are reduced and the balloon 25 is inflated. Flows are then returned to the operating levels and a suitable cardioplegic agent is introduced into the aortic root. Once the full volume of cardioplegic agent has been given and cardiac arrest achieved, the lumen is then used to vent the heart. The heart may then be operated on or examined by insertion of instrumentation 37 such as a cardioscope or a laser into the heart through the lumen 34 or through atrial trocars. Alternatively, with the heart on by-pass as described above the heart can be approached by an open method by an incision other than median sternotomy.
- instrumentation 37 such as a cardioscope or a laser
- Venting of the left ventricle may be effected by providing an extended cannula 38 projecting from lumen 33 into the left ventricle (see FIG. 2) or by simply applying negative pressure to the venting lumen 33 of the aortic catheter.
- To reverse cardioplegic arrest the body is rewarmed and the balloon 27 deflated. Aortic blood is thus allowed to perfuse the heart. Whilst the body remains supported by peripheral cardiopulmonary by-pass, the return of the heart rhythm is awaited. External defibrillation my be necessary. Weaning from by-pass is then completed in a routine fashion.
Abstract
A process for inducing cardioplegic arrest of a heart in situ in a patients body. comprising maintaining the patient's systemic circulation by peripheral cardiopulmonary by-pass, occluding the ascending aorta through a percutaneously placed arterial balloon catheter, venting the left side of the heart, and introducing a cardioplegic agent into the coronary circulation. This procedure readies the heart for a variety of surgical procedures that can be performed percutaneously through lumina in the catheter. An aortic catheter for use in the process is also described.
Description
- This application is a continuation of co-pending application Serial No. 09/085,760, filed May 28, 1998, which is a divisional of application Serial No. 08/879,545 filed Jun. 20, 1997, now issued as U.S. Pat. No. 5,762,624, which is a continuation of application Serial No. 08/614,634 filed Mar. 13, 1996, now abandoned, which is a divisional of application Serial No. 08/427,384 filed Apr. 24, 1995, now issued as U.S. Pat. No. 5,752,496, which is a divisional of application Serial No. 08/159,815 filed Nov. 30, 1993, now reissued as U.S. Pat. No. RE35352. The complete disclosures of all of these applications are hereby incorporated herein by reference for all purposes.
- The present invention relates to a method for inducing cardioplegic arrest in a heart and to catheters for use in that method.
- The use of extracorporeal cardiopulmonary by-pass for cardiac support has become well established. This use has, however, involved median stemotomy or less commonly thoracotomy with all of the trauma that necessarily accompanies such a major surgical procedure.
- The present invention contemplates, at least in its preferred embodiments, the possibility of effective ascending aortic occlusion, cardioplegia, venting, right heart deflation and topical cooling in association with extracorporeal cardiopulmonary bypass all without necessitating a median sternotomy or other thoracic incision.
- In a first aspect the present invention consists in a method for inducing cardioplegic arrest of a heart in situ in a patient's body, comprising the steps of:
- (a) maintaining systemic circulation with peripheral cardiopulmonary by-pass;
- (b) occluding the ascending aorta through a percutaneously placed arterial balloon catheter;
- (c) introducing a cardioplegic agent into the coronary circulation; and
- (d) venting the left side of the heart.
- The method according to the present invention may be carried out on humans or other mammalian animals. The method is of particular applicability in humans as it allows an alternative approach to open heart surgery and the development of closed cardioscopic surgery. The method according to the invention enables a percutaneous by-pass system to be associated with cardioplegia, venting and cooling of the heart which subverts the need for median stemotomy. This may, in turn, reduce the complications of the surgery.
- The maintenance of the systemic circulation involves establishing a cardiopulmonary by-pass. The blood may be drawn into the by-pass merely by positioning a percutaneous catheter into the right atrium and/or into one or both of the vena cavae through which venous blood may be drawn from the heart into an extracorporeal pump oxygenator. In more preferred embodiments of the invention a single catheter with two inflatable cuffs, or two separate catheters, each with an inflatable cuff are introduced into the vena cavae to occlude them adjacent to their right atrial inlets. This allows isolation of the right atrium and allows blood to be drawn from the vena cavae into the by-pass system. There is also preferably provision for percutaneous communication via one catheter with the right atrium to allow infusion of saline into the right atrium. This infusion has the advantage that it allows the heart to be cooled and improves visual acuity within the right heart allowing direct cardioscopic examination and/or intervention.
- The catheter used to decompress the right atrium and to draw blood into the by-pass is preferably introduced through the femoral vein by percutaneous puncture or direct cut down. If other than simple venous drainage is required catheters with inflatable cuffs, as described above, are placed preferably such that in inflatable cuff of the cannula is positioned within each of the inferior (suprahepatic) and superior vena cavae. There is preferably a lumen in the cannula acting as a common blood outlet from the vena cavae leading to the pump oxygenator. A separate lumen is preferably used to infuse saline between the two inflated cuffs into the right atrium. If, alternatively, separate catheters are used to occlude each of the inferior and superior vena cavae than the cannula for the inferior vena cavae is preferably introduced percutaneously from the femoral vein and that for the superior vena cavae is introduced percutaneously through the jugular or subclavian vein.
- The ascending aorta is preferably occluded by a balloon catheter introduced percutaneously through the femoral artery. This catheter must carry adjacent its tip an inflatable cuff or balloon of sufficient size that upon being inflated it is able to completely occlude the ascending aorta. The length of the balloon should preferably not be so long as to impede the flow of blood or other solution to the coronary arteries or to the brachiocephalic, left carotid or left subclavian arteries. A balloon length of about 40 mm and diameter of about 35 mm is suitable in humans. The balloon is of a cylindrical shape to fully and evenly accommodate the lumen of the ascending aorta. This maximizes the surface area contact with the aorta, and allows for even distribution of occlusive pressure.
- The balloon of the catheter is preferably inflated with a saline solution to avoid the possibility of introducing into the patient an air embolism in the event that the balloon ruptured. The balloon should be inflated to a pressure sufficient to prevent regurgitation of blood into the aortic root and to prevent migration of the balloon into the root whilst not being so high as to cause damage or dilation to the aortic wall. An intermediate pressure of the order of 350 mmHg has been proven effective in trials.
- The aortic catheter is preferably introduced under fluoroscopic guidance over a suitable guidewire. Transoesophageal echocardiography can alternatively be used for positioning as has been described with reference to the venous catheter. The catheter may serve a number of separate functions and the number of lumina in the catheter will depend upon how many of those functions the catheter is to serve. The catheter can be used to introduce the cardioplegic agent, normally in solution, into the aortic root via one lumen. The luminal diameter will preferably be such that a flow of the order of 250-500 ml/min of cardioplegic solution can be introduced into the aortic root under positive pressure to perfuse adequately the heart by way of the coronary arteries. The same lumen can, by applying negative pressure to the lumen from an outside source, effectively vent the left heart of blood or other solutions. It may also be desirable to introduce medical instruments and/or a cardioscope into the heart through another lumen in the catheter. The lumen should be of a diameter suitable to pass a fibre-optic light camera of no greater than 3 mm diameter. It is however, preferable that the diameter and cross-sectional design of the internal lumina is such that the external diameter of the catheter in its entirety is small enough to allow its introduction into the adult femoral artery by either percutaneous puncture or direct cut-down
- The oxygenated blood returning to the body from the by-pass system may be conveyed into the aorta from another lumen in the cannula carrying the balloon. In this case the returning blood is preferably discarded from the catheter in the external iliac artery. In another embodiment of the invention, and in order to reduce the diameter of the catheter carrying the balloon, a separate arterial catheter of known type may be used to return blood to the patient from the by-pass system. In this case a short catheter is positioned in the other femoral artery to provide systemic arterial blood from the by-pass system. The control end of the catheter, i.e. that end that remains outside of the body, should have separate ports of attachment for the lumina. The catheter length should be approximately 900 mm for use in humans.
- The cardioplegic agent may be any of the known materials previously known to be useful, or in the future found to be useful, as cardiopiegic agents. The agent is preferably infused as a solution into the aortic root through one of the lumina of the aortic catheter.
- In another aspect the present invention consists in a catheter for use in occluding the ascending aorta comprising an elongate tube having one or more continuous lumina along its length, an inflatable cuff is disposed about the tube adjacent one end thereof, the cuff being of such a size that upon being inflated it is able to occlude the ascending aorta of a patient.
- The catheter and method according to the present invention can be used to induce cardioplegic arrest and may be used in a number of surgical procedures. These include the following:
- 1. Coronary artery revascularization such as:
- (a) angioscopic laser introduction or angioscopic balloon angioplasty catheter into the coronary arteries via one lumen of the aortic catheter, or
- (b) thoraco dissection of one or both of the mammary arteries with revascularization achieved by distal anastomoses of the internal mammary arteries to coronary arteries via a small left anterior thoracotomy.
- 2. Secundum—type atrial septal defect repair such as by:
- (a) “Closed” cardioscopic closure, or
- (b) Closure as an “open” procedure via a mini-right thoracotomy.
- 3. Sinus venosus defect repairs similar to 2 above.
- 4. Infundibular stenosis relief by cardioscopic techniques.
- 5. Pulmonary valvular stenosis relief by cardioscopic techniques.
- 6. Mitral valve surgery via a small right thoracotomy.
- 7. Aortic stenosis relief by the introduction of instrumentation via a lumen in the aortic catheter into the aortic root.
- 8. Left ventricular aneurysm repair via a small left anterior thoracotomy.
- Hereinafter given by way of example are preferred embodiments of the present invention described with reference to the accompanying drawings in which:
- FIG. 1 is a schematic partly cut-away representation of a patient's heart having percutaneous catheters placed therein for carrying out the method according to the present invention:
- FIG. 2 is a similar view to FIG. 1 showing the aortic catheter in position but including an angioscope and a left ventricular venting cannula introduced into the aortic root and left ventricle respectively, via separate lumina within the aortic catheter:
- FIG. 3 is a front elevational view of part of the vascular system or a patient showing, inter alia, the aortic balloon catheter positioned in the ascending aorta via the femoral artery:
- FIG. 4 is a side elevational view of the control end of the aortic catheter according to the present invention:
- FIG. 5 is a partly cut away side elevational view of the balloon end of the catheter of FIG. 4 in an inflated condition:
- FIG. 6a is a cross-sectional view of the catheter of FIG. 4 intermediate the control end and the balloon end;
- FIG. 6b is an alternative cross-sectional arrangement of the lumina in the catheter of FIG. 4;
- FIG. 7 is a cross-sectional view through the balloon end of the catheter of FIG. 4;
- FIGS. 8a and 8 b show schematically two alternative arrangements to the catheter shown in FIG. 4;
- FIGS. 9a and 9 b show schematically two alternative catheter arrangements for the isolation of the right atrium and venous drainage.
- The
heart 10 of FIGS. 1 and 2 is positioned in the living body of a patient and is accessed percutaneously. - In order to induce cardioplegia in the heart while maintaining the patient it is necessary to divert the patient's blood circulation through an extracorporeal cardiopulmonary by-pass system. This is achieved by isolating the
heart 10 on both the venous and arterial sides using appropriate percutaneously insertedvenous catheter 11,aortic balloon catheter 12, and if thiscatheter 12 doesn't have provision for arterial blood return, arterial catheter 39 (see FIG. 3). The venous outflow and arterial inflow lumina of thecatheters - In the case of the use of a single venous double-ballooned
catheter 11, as is shown in FIG. 1, thecatheter 11 is inserted through the femoral vein preferably. A suitable guide wire is initially inserted and thecatheter 11 is then introduced in known manner under fluoroscopic guidance. Thecatheter 11 includes a pair of separatelyinflatable balloons catheter 11. Theballoon 14 is adapted to occlude thesuperior vena cavae 16 while theballoon 15 is adapted to occlude the suprahepaticinferior vena cavae 17. A blood withdrawal lumen in thecatheter 11 has aninlet orifice 18 flush with theballoon 14, to avoid venous collapse during blood flow into thecatheter 11, and a series ofinlet slots 19 in the inferior vena cavae. Blood drawn into theinlets catheter 11 is oxygenated and returned to the patient in a manner which will be hereinafter described. - A separate lumen in the
catheter 11 opens into theright atrium 22 throughaperture 21 to allow evacuation of blood from the right heart and the infusion of saline to induce topical cooling and/or to improve visual acuity within the right heart. - In use, after the
catheter 11 has been positioned the balloons may be inflated or deflated to vary the rate of venous return to theright atrium 22 and therefore the degree of decompression of the left heart. Venous drainage may be effected by gravitational drainage or by applying a degree of negative pressure to assist flow into the pump oxygenator. It will be appreciated that the distance between theballoons separate catheters cannula 11 b being introduced as has been described above and thecannula 11 c being introduced through the jugular or subclavian vein. It will also be appreciated that for simple operations not requiring complete occlusion of the right atrium it is possible to merely insert a simple catheter 1I into the right atrium to draw blood into the by-pass system as is seen in FIG. 2. Positioning under fluoroscopic guidance is not essential in this case. - The
catheter 12 is positioned in the manner described above with its free end located in the ascendingaorta 23. Thecatheter 12 is so positioned by insertion preferably through thefemoral artery 24 and via the descendingaorta 25 as is seen in FIG. 3. - If desired a fluoroscopic dye may be introduced into the
aortic root 26 through thecatheter 12 for accurate positioning of the tip of thecatheter 12 relative to theaortic root 26 and the coronary ostia. - The
catheter 12 carries at its free end aballoon 27. Theballoon 27 is arranged to be inflated with saline from aninflation control device 28 of known type through a lumen in thecatheter 12. Thedevice 28 is fitted with apressure gauge 29 to allow the operator to control the inflation of theballoon 27. The pressure of the fully inflatedballoon 27 should be of the order of 350 mmHg so as to be sufficient to effectively occlude the aorta and to prevent the balloon moving while not being so great as to cause damage to the aortic wall. Theballoon 27 should have a maximum diameter sufficient to occlude the aorta and for this purpose the maximum diameter should be about 35 mm. Theballoon 27 should have a length of about 40 mm so as not to be so long as to occlude or impede blood flow to the coronary arteries or to the brachiocephalic, subclavian or carotid arteries. If necessary in any given patient the required length and diameter of the balloon may be determined by angiographic. X-ray examination or echocardiography and an appropriately sized catheter selected on that basis. - The
balloon 27 is preferably connected to thelumen 32 through which it is inflated at the end of theballoon 27 distal to the tip of thecatheter 12 through orifice 31 (see FIG. 5). This allows the tip of the catheter to contain fewer lumina than the remainder of the catheter. Accommodation of the deflated balloon around the tip of the catheter is thus possible without adding to the diameter of the tip as compared with the rest of thecatheter 12. - The
catheter 12 includes a plurality of lumina (see FIGS. 6 and 7). In addition to theballoon inflation lumen 32 there is at least a single venting/cardioplegia lumen 33 of circular cross-section. There may be a separate and extracircular lumen 34 for instrumentation. If two lumens are present the venting/cardioplegia lumen may be circular or crescent shaped in cross-section (FIGS. 6a, 6 b). The diameter of the various lumina should be as small as practicable commensurate with the intended use. In addition, there may be acontinuous lumen 35 through which arterial blood is returned from the by-pass. This may flow out of thecatheter 12 through an orifice in the region of the external iliac artery. In alternative embodiments of the invention such as shown in FIGS. 3 and 8 thearterial return lumen 35 may comprise itsown catheter 39 of known type introduced into the other femoral artery or some other suitable artery. - In use the
catheter 12 is introduced percutaneously by puncture or cutdown as has been described and once blood flow through the by-pass is established (including systemic cooling) flows are reduced and theballoon 25 is inflated. Flows are then returned to the operating levels and a suitable cardioplegic agent is introduced into the aortic root. Once the full volume of cardioplegic agent has been given and cardiac arrest achieved, the lumen is then used to vent the heart. The heart may then be operated on or examined by insertion ofinstrumentation 37 such as a cardioscope or a laser into the heart through thelumen 34 or through atrial trocars. Alternatively, with the heart on by-pass as described above the heart can be approached by an open method by an incision other than median sternotomy. Venting of the left ventricle may be effected by providing anextended cannula 38 projecting fromlumen 33 into the left ventricle (see FIG. 2) or by simply applying negative pressure to theventing lumen 33 of the aortic catheter. To reverse cardioplegic arrest the body is rewarmed and theballoon 27 deflated. Aortic blood is thus allowed to perfuse the heart. Whilst the body remains supported by peripheral cardiopulmonary by-pass, the return of the heart rhythm is awaited. External defibrillation my be necessary. Weaning from by-pass is then completed in a routine fashion.
Claims (13)
1. A method for inducing cardioplegic arrest of a heart in situ in a patient's body, comprising the steps of:
(a) maintaining systemic circulation with peripheral cardiopulmonary by-pass:
(b) occluding the ascending aorta through a percutaneously placed arterial balloon catheter;
(c) introducing a cardioplegic agent into the coronary circulation; and
(d) venting the left side of the heart.
2. A method as claimed in claim 1 in which the ascending aorta is occluded by a balloon catheter percutaneously placed through one of the femoral arteries.
3. A method as claimed in claim 2 in which the catheter has a lumen or lumina through which the cardioplegic agent or medical instruments and/or a cardioscope may be introduced into the heart and/or through which the left side of the heart is vented.
4. A method as claimed in claim 1 in which the systemic circulation is maintained through a cardiopulmonary by-pass that includes a percutaneous catheter introduced into the right atrium and/or into one or both of the vena cavae to draw venous blood into the cardiopulmonary by-pass.
5. A method as claimed in claim 4 in which the percutaneous catheter has two inflatable cuffs, each cuff being adapted to occlude one of the vena cavae and the percutaneous catheter having a lumen or lumenae to draw venous blood from each of the vena cavae into the cardiopulmonary by-pass.
6. A method as claimed in claim 5 in which saline is introduced into the right atrium through a lumen in the percutaneous catheter which opens between the two cuffs.
7. A method as claimed in claim 4 in which the percutaneous catheter is introduced into the heart through the femoral vein.
8. A method as claimed in claim 1 in which the systemic circulation is maintained through a cardiopulmonary by-pass that includes an oxygenated blood return catheter introduced into one of the femoral arteries.
9. A balloon catheter for use in occluding the ascending aorta comprising an elongate tube having one or more continuous lumina along its length, an inflatable cuff disposed about the tube adjacent one end thereof, the cuff being of such a size that upon being inflated it is able to occlude the ascending aorta of a patient.
10. A catheter as claimed in claim 9 in which the inflatable cuff is of such a length that its occlusion of the ascending aorta will not impede blood flow to the coronary arteries onto the brachiocephalic, left carotid or left subclavian arteries.
11. A catheter as claimed in claim 9 in which the inflatable cuff is cylindrical when inflated and has a length of about 40 mm and a diameter of about 35 mm when inflated.
12. A catheter as claimed in claim 10 in which the catheter is of a length of about 900 mm.
13. A catheter as claimed in claim 9 in which the inflatable cuff is connected to the lumen of the catheter through which it is inflated at the end of the cuff distal to the adjacent end of the catheter.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/029,681 US20020068922A1 (en) | 1992-12-03 | 2001-12-21 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL617U | 1992-12-03 | ||
AUPL617092 | 1992-12-03 | ||
US08/159,815 US5433700A (en) | 1992-12-03 | 1993-11-30 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US08/427,384 US5725496A (en) | 1992-12-03 | 1995-04-24 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US61463496A | 1996-03-13 | 1996-03-13 | |
US08/879,545 US5762624A (en) | 1992-12-03 | 1997-06-20 | Venous cannula |
US09/085,760 US5971973A (en) | 1993-11-30 | 1998-05-28 | Method of occluding a patient's ascending aorta and returning oxygenated blood to the patient from a bypass system |
US09/358,132 US6451004B1 (en) | 1993-11-30 | 1999-07-19 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US10/029,681 US20020068922A1 (en) | 1992-12-03 | 2001-12-21 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/358,132 Division US6451004B1 (en) | 1992-12-03 | 1999-07-19 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020068922A1 true US20020068922A1 (en) | 2002-06-06 |
Family
ID=26856338
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/614,535 Expired - Lifetime US5759170A (en) | 1993-11-30 | 1996-03-13 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US09/085,760 Expired - Lifetime US5971973A (en) | 1992-12-03 | 1998-05-28 | Method of occluding a patient's ascending aorta and returning oxygenated blood to the patient from a bypass system |
US09/358,132 Expired - Fee Related US6451004B1 (en) | 1992-12-03 | 1999-07-19 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US10/029,681 Abandoned US20020068922A1 (en) | 1992-12-03 | 2001-12-21 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/614,535 Expired - Lifetime US5759170A (en) | 1993-11-30 | 1996-03-13 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US09/085,760 Expired - Lifetime US5971973A (en) | 1992-12-03 | 1998-05-28 | Method of occluding a patient's ascending aorta and returning oxygenated blood to the patient from a bypass system |
US09/358,132 Expired - Fee Related US6451004B1 (en) | 1992-12-03 | 1999-07-19 | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
Country Status (1)
Country | Link |
---|---|
US (4) | US5759170A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040097958A1 (en) * | 2002-07-31 | 2004-05-20 | Whitman Michael P. | Orifice introducer device |
US7951071B2 (en) | 1999-06-02 | 2011-05-31 | Tyco Healthcare Group Lp | Moisture-detecting shaft for use with an electro-mechanical surgical device |
US8025199B2 (en) | 2004-02-23 | 2011-09-27 | Tyco Healthcare Group Lp | Surgical cutting and stapling device |
US8357144B2 (en) | 1999-06-02 | 2013-01-22 | Covidien, LP | Electro-mechanical surgical device |
WO2015013612A1 (en) * | 2013-07-25 | 2015-01-29 | Merit Medical Systems, Inc. | Balloon catheter systems and methods |
US20200215312A1 (en) * | 2014-08-06 | 2020-07-09 | Edwards Lifesciences Corporation | Multi-lumen cannulae |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5478309A (en) * | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US7678098B2 (en) * | 1996-04-10 | 2010-03-16 | Endoscopic Technologies, Inc. | Venous cannula and cardiopulmonary bypass system |
US6440146B2 (en) | 1996-07-23 | 2002-08-27 | United States Surgical Corporation | Anastomosis instrument and method |
US6258120B1 (en) * | 1997-12-23 | 2001-07-10 | Embol-X, Inc. | Implantable cerebral protection device and methods of use |
US6099506A (en) | 1997-09-26 | 2000-08-08 | Macoviak; John A. | Introducer and perfusion cannula |
WO1999029363A1 (en) * | 1997-12-08 | 1999-06-17 | Cardeon Corporation | Aortic catheter and methods for inducing cardioplegic arrest and for selective aortic perfusion |
US6216703B1 (en) | 1998-05-08 | 2001-04-17 | Thermatrx, Inc. | Therapeutic prostatic thermotherapy |
US6461327B1 (en) * | 1998-08-07 | 2002-10-08 | Embol-X, Inc. | Atrial isolator and method of use |
US6969379B1 (en) * | 1998-08-27 | 2005-11-29 | A-Med Systems, Inc. | Intravascular cannulation apparatus and methods of use |
US6726651B1 (en) | 1999-08-04 | 2004-04-27 | Cardeon Corporation | Method and apparatus for differentially perfusing a patient during cardiopulmonary bypass |
US6210363B1 (en) | 1999-02-23 | 2001-04-03 | Cardeon Corporation | Methods and devices for occluding a vessel and performing differential perfusion |
CA2397121C (en) | 2000-01-18 | 2009-04-07 | Tyco Healthcare Group Lp | Anastomosis instrument and method for performing same |
EP1255582A1 (en) | 2000-02-04 | 2002-11-13 | Endoscopic Technologies, Inc. | Aortic balloon catheter with improved positioning and balloon stability |
WO2001056641A1 (en) | 2000-02-04 | 2001-08-09 | C. R. Bard, Inc. | Triple lumen stone balloon catheter and method |
US6640138B1 (en) | 2000-08-04 | 2003-10-28 | Thermatrx, Inc. | Apparatus and method for heat treatment of tissue |
US6554819B2 (en) * | 2001-01-09 | 2003-04-29 | Mount Sinai School Of Medicine Of New York University | Method and device for preventing contrast associated nephropathy |
CA2435209C (en) * | 2001-01-24 | 2009-08-25 | Tyco Healthcare Group Lp | Anastomosis instrument and method for performing same |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20070160645A1 (en) * | 2001-10-25 | 2007-07-12 | Jakob Vinten-Johansen | PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs |
US7686781B2 (en) | 2001-10-25 | 2010-03-30 | Emory University | Catheter for modified perfusion |
WO2006069170A2 (en) * | 2004-12-22 | 2006-06-29 | Emory University | Therapeutic adjuncts to enhance the organ protective effects of postconditioning |
US7048756B2 (en) * | 2002-01-18 | 2006-05-23 | Apasara Medical Corporation | System, method and apparatus for evaluating tissue temperature |
US6769594B2 (en) | 2002-05-31 | 2004-08-03 | Tyco Healthcare Group, Lp | End-to-end anastomosis instrument and method for performing same |
US20030130610A1 (en) * | 2002-12-09 | 2003-07-10 | Mager Larry F. | Aortic balloon catheter with improved positioning and balloon stability |
US20050010241A1 (en) * | 2003-07-09 | 2005-01-13 | Keith Milliman | Anastomosis instrument and method for performing same |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
NZ549911A (en) * | 2006-10-19 | 2009-04-30 | Syft Technologies Ltd | Improvements in or relating to SIFT-MS instruments |
US8353893B2 (en) * | 2007-03-07 | 2013-01-15 | Zoll Circulation, Inc. | System and method for rapidly cooling cardiac arrest patient |
WO2010039828A1 (en) * | 2008-10-01 | 2010-04-08 | Teleflex Medical Incorporated | Article containing segregated biguanide and lewis acid |
US8413872B2 (en) | 2009-10-28 | 2013-04-09 | Covidien Lp | Surgical fastening apparatus |
US8449565B2 (en) | 2011-07-21 | 2013-05-28 | Francis Duhay | Approaches to venous occlusion for embolus management |
US9358042B2 (en) | 2013-03-13 | 2016-06-07 | The Spectranetics Corporation | Expandable member for perforation occlusion |
US10449336B2 (en) | 2015-08-11 | 2019-10-22 | The Spectranetics Corporation | Temporary occlusions balloon devices and methods for preventing blood flow through a vascular perforation |
US10499892B2 (en) | 2015-08-11 | 2019-12-10 | The Spectranetics Corporation | Temporary occlusion balloon devices and methods for preventing blood flow through a vascular perforation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5024668A (en) * | 1987-01-20 | 1991-06-18 | Rocky Mountain Research, Inc. | Retrograde perfusion system, components and method |
US5452733A (en) * | 1993-02-22 | 1995-09-26 | Stanford Surgical Technologies, Inc. | Methods for performing thoracoscopic coronary artery bypass |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3769960A (en) * | 1972-04-17 | 1973-11-06 | Us Health Education & Welfare | Intra-aortic balloon system |
US3833003A (en) * | 1972-07-05 | 1974-09-03 | A Taricco | Intravascular occluding catheter |
US4173981A (en) * | 1977-05-23 | 1979-11-13 | University Of Utah | Cannula for arterial and venous bypass cannulation |
US4248224A (en) * | 1978-08-01 | 1981-02-03 | Jones James W | Double venous cannula |
US4276874A (en) * | 1978-11-15 | 1981-07-07 | Datascope Corp. | Elongatable balloon catheter |
US4531936A (en) * | 1981-01-29 | 1985-07-30 | Gordon Robert T | Device and method for the selective delivery of drugs to the myocardium |
US4527549A (en) * | 1982-08-05 | 1985-07-09 | Shelhigh Inc. | Method of and means for intraaortic assist |
US4540399A (en) * | 1983-02-01 | 1985-09-10 | Ken Litzie | Emergency bypass system |
US4606347A (en) * | 1983-03-25 | 1986-08-19 | Thomas J. Fogarty | Inverted balloon catheter having sealed through lumen |
US5275622A (en) * | 1983-12-09 | 1994-01-04 | Harrison Medical Technologies, Inc. | Endovascular grafting apparatus, system and method and devices for use therewith |
US4902273A (en) * | 1984-02-21 | 1990-02-20 | Choy Daniel S J | Heart assist device |
US4680029A (en) * | 1984-02-23 | 1987-07-14 | Sherwood Medical Company | Vena caval catheter |
US4592340A (en) * | 1984-05-02 | 1986-06-03 | Boyles Paul W | Artificial catheter means |
US4705507A (en) * | 1984-05-02 | 1987-11-10 | Boyles Paul W | Arterial catheter means |
US4664125A (en) * | 1984-05-10 | 1987-05-12 | Pinto John G | Flow-occluding method for the diagnosis of heart conditions |
FR2577423B1 (en) * | 1985-02-20 | 1989-05-05 | Gilles Karcher | CIRCULATORY AND CORONARY ASSISTANCE PUMP WITH INTRA-AORTIC BALLOONS |
US4741328A (en) * | 1985-03-14 | 1988-05-03 | Shlomo Gabbay | Means for intraaortic assist and method of positioning a catheter therefor |
US4601713A (en) * | 1985-06-11 | 1986-07-22 | Genus Catheter Technologies, Inc. | Variable diameter catheter |
US4785795A (en) * | 1985-07-15 | 1988-11-22 | Abiomed Cardiovascular, Inc. | High-frequency intra-arterial cardiac support system |
NL8502382A (en) * | 1985-08-30 | 1987-03-16 | Martinus Jacobus Antonius Joha | CATHETER SUITABLE FOR MULTIPLE PURPOSES. |
US4655746A (en) * | 1985-12-02 | 1987-04-07 | Target Therapeutics | Catheter device |
US4990139A (en) * | 1986-09-10 | 1991-02-05 | Jang G David | Tandem independently inflatable/deflatable multiple diameter balloon angioplasty catheter systems |
US4804365A (en) * | 1987-02-13 | 1989-02-14 | C. R. Bard | Vascular cannulae for transfemoral cardiopulmonary bypass and method of use |
US4902272A (en) * | 1987-06-17 | 1990-02-20 | Abiomed Cardiovascular, Inc. | Intra-arterial cardiac support system |
US4889137A (en) * | 1988-05-05 | 1989-12-26 | The United States Of America As Reprsented By The Department Of Health And Human Services | Method for improved use of heart/lung machine |
JPH0255064A (en) * | 1988-08-03 | 1990-02-23 | Toa O | Skin removal for throm bus in blood vessel using catheter and throm bus removing system in blood vessel using catheter |
US5011469A (en) * | 1988-08-29 | 1991-04-30 | Shiley, Inc. | Peripheral cardiopulmonary bypass and coronary reperfusion system |
CH676426A5 (en) * | 1988-09-27 | 1991-01-31 | Schneider Shiley Ag | |
US4943275A (en) * | 1988-10-14 | 1990-07-24 | Abiomed Limited Partnership | Insertable balloon with curved support |
US4877035A (en) * | 1988-10-12 | 1989-10-31 | Trustees Of The University Of Pennsylvania | Measurement of the end-systolic pressure-volume relation using intraaortic balloon occlusion |
US5176619A (en) * | 1989-05-05 | 1993-01-05 | Jacob Segalowitz | Heart-assist balloon pump with segmented ventricular balloon |
US5045072A (en) * | 1989-06-13 | 1991-09-03 | Cordis Corporation | Catheter having highly radiopaque, flexible tip |
US5176628A (en) | 1989-10-27 | 1993-01-05 | Alcon Surgical, Inc. | Vitreous cutter |
US5122115A (en) * | 1989-12-08 | 1992-06-16 | Temple University | Multilumen angiography catheter |
US5209723A (en) * | 1990-01-08 | 1993-05-11 | The Curators Of The University Of Missouri | Multiple lumen catheter for hemodialysis |
US5306249A (en) * | 1990-01-12 | 1994-04-26 | Don Michel T Anthony | Method of treating body passage walls |
US5460610A (en) * | 1990-01-12 | 1995-10-24 | Don Michael; T. Anthony | Treatment of obstructions in body passages |
US5116305A (en) * | 1990-02-01 | 1992-05-26 | Abiomed, Inc. | Curved intra aortic balloon with non-folding inflated balloon membrane |
US5186713A (en) * | 1990-11-01 | 1993-02-16 | Baxter International Inc. | Extracorporeal blood oxygenation system and method for providing hemoperfusion during transluminal balloon angioplasty procedures |
US5308320A (en) * | 1990-12-28 | 1994-05-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method |
AR245376A1 (en) * | 1991-02-25 | 1994-01-31 | Liliana Rosa Grinfeld Y Robert | Arterial profusion nozzle, for extra-corporal circulation and other uses. |
US5219326A (en) * | 1991-03-27 | 1993-06-15 | Hattler Brack G | Inflatable percutaneous oxygenator |
US5295958A (en) * | 1991-04-04 | 1994-03-22 | Shturman Cardiology Systems, Inc. | Method and apparatus for in vivo heart valve decalcification |
US5167628A (en) * | 1991-05-02 | 1992-12-01 | Boyles Paul W | Aortic balloon catheter assembly for indirect infusion of the coronary arteries |
US5490837A (en) * | 1991-07-05 | 1996-02-13 | Scimed Life Systems, Inc. | Single operator exchange catheter having a distal catheter shaft section |
US5281203A (en) * | 1991-07-05 | 1994-01-25 | Scimed Life Systems, Inc. | Guide wire and sheath for single operator exchange |
US5433700A (en) * | 1992-12-03 | 1995-07-18 | Stanford Surgical Technologies, Inc. | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US5458574A (en) * | 1994-03-16 | 1995-10-17 | Heartport, Inc. | System for performing a cardiac procedure |
US5195942A (en) * | 1991-08-12 | 1993-03-23 | Institute Of Critical Care Medicine | Cardiac arrest treatment |
US5330498A (en) * | 1991-12-17 | 1994-07-19 | Hill John D | Blood vessel occlusion trocar |
US5254097A (en) * | 1992-01-06 | 1993-10-19 | Datascope Investment Corp. | Combined percutaneous cardiopulmonary bypass (PBY) and intra-aortic balloon (IAB) access cannula |
NL9201222A (en) * | 1992-07-08 | 1994-02-01 | Marinus Adrianus Josephus Mari | RETURN CANULE. |
US5487730A (en) * | 1992-12-30 | 1996-01-30 | Medtronic, Inc. | Balloon catheter with balloon surface retention means |
US5425705A (en) * | 1993-02-22 | 1995-06-20 | Stanford Surgical Technologies, Inc. | Thoracoscopic devices and methods for arresting the heart |
US5451207A (en) * | 1994-04-25 | 1995-09-19 | The Regents Of The University Of California | Method of coronary plaque removal with bypass and perfusion |
US5478309A (en) * | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
-
1996
- 1996-03-13 US US08/614,535 patent/US5759170A/en not_active Expired - Lifetime
-
1998
- 1998-05-28 US US09/085,760 patent/US5971973A/en not_active Expired - Lifetime
-
1999
- 1999-07-19 US US09/358,132 patent/US6451004B1/en not_active Expired - Fee Related
-
2001
- 2001-12-21 US US10/029,681 patent/US20020068922A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5024668A (en) * | 1987-01-20 | 1991-06-18 | Rocky Mountain Research, Inc. | Retrograde perfusion system, components and method |
US5452733A (en) * | 1993-02-22 | 1995-09-26 | Stanford Surgical Technologies, Inc. | Methods for performing thoracoscopic coronary artery bypass |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9247940B2 (en) | 1999-06-02 | 2016-02-02 | Covidien Lp | Surgical cutting and stapling device |
US10335143B2 (en) | 1999-06-02 | 2019-07-02 | Covidien Lp | Surgical cutting and stapling device |
US10314659B2 (en) | 1999-06-02 | 2019-06-11 | Covidien Lp | Electro-mechanical surgical device |
US8357144B2 (en) | 1999-06-02 | 2013-01-22 | Covidien, LP | Electro-mechanical surgical device |
US9364200B2 (en) | 1999-06-02 | 2016-06-14 | Covidien Lp | Electro-mechanical surgical device |
US8628467B2 (en) | 1999-06-02 | 2014-01-14 | Covidien Lp | Moisture-detecting shaft for use with an electro-mechanical surgical device |
US7951071B2 (en) | 1999-06-02 | 2011-05-31 | Tyco Healthcare Group Lp | Moisture-detecting shaft for use with an electro-mechanical surgical device |
US9113847B2 (en) | 1999-06-02 | 2015-08-25 | Covidien Lp | Electro-mechanical surgical device |
US9033868B2 (en) | 1999-06-02 | 2015-05-19 | Covidien Lp | Couplings for interconnecting components of an electro-mechanical surgical device |
US8814785B2 (en) | 2002-07-31 | 2014-08-26 | Covidien Lp | Orifice introducer device |
US9554824B2 (en) | 2002-07-31 | 2017-01-31 | Covidien Lp | Orifice introducer device |
US20040097958A1 (en) * | 2002-07-31 | 2004-05-20 | Whitman Michael P. | Orifice introducer device |
US7874981B2 (en) | 2002-07-31 | 2011-01-25 | Tyco Healthcare Group Lp | Orifice introducer device |
US8025199B2 (en) | 2004-02-23 | 2011-09-27 | Tyco Healthcare Group Lp | Surgical cutting and stapling device |
US11219452B2 (en) | 2004-02-23 | 2022-01-11 | Covidien Lp | Surgical cutting and stapling device |
WO2015013612A1 (en) * | 2013-07-25 | 2015-01-29 | Merit Medical Systems, Inc. | Balloon catheter systems and methods |
US10086173B2 (en) | 2013-07-25 | 2018-10-02 | Merit Medical Systems, Inc. | Balloon catheter systems and methods |
US10130797B2 (en) | 2013-07-25 | 2018-11-20 | Merit Medical Systems, Inc. | Balloon catheter systems and methods |
US11219749B2 (en) | 2013-07-25 | 2022-01-11 | Merit Medical Systems, Inc. | Balloon catheter systems and methods |
US20200215312A1 (en) * | 2014-08-06 | 2020-07-09 | Edwards Lifesciences Corporation | Multi-lumen cannulae |
US11857744B2 (en) * | 2014-08-06 | 2024-01-02 | Edwards Lifesciences Corporation | Multi-lumen cannulae |
Also Published As
Publication number | Publication date |
---|---|
US6451004B1 (en) | 2002-09-17 |
US5759170A (en) | 1998-06-02 |
US5971973A (en) | 1999-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6451004B1 (en) | Method for intraluminally inducing cardioplegic arrest and catheter for use therein | |
US5725496A (en) | Method for intraluminally inducing cardioplegic arrest and catheter for use therein | |
EP0836501B1 (en) | Endovascular system for arresting the heart | |
US6932792B1 (en) | Antegrade cardioplegia catheter and method | |
AU691893B2 (en) | System for performing a cardiac procedure | |
US5584803A (en) | System for cardiac procedures | |
US6866650B2 (en) | System for cardiac procedures | |
US5769812A (en) | System for cardiac procedures | |
US5558644A (en) | Retrograde delivery catheter and method for inducing cardioplegic arrest | |
US7131447B2 (en) | Methods and systems for performing thoracoscopic coronary bypass and other procedures | |
US6398752B1 (en) | Method of occluding a patient's ascending aorta and delivery cardioplegic fluid | |
US6241699B1 (en) | Catheter system and method for posterior epicardial revascularization and intracardiac surgery on a beating heart | |
US7846129B2 (en) | Multichannel catheter | |
US6027476A (en) | Methods and systems for performing thoracoscopic coronary bypass and other procedures | |
WO1999004836A9 (en) | Catheter system and method for posterior epicardial revascularization and intracardiac surgery on a beating heart | |
WO1999015227A1 (en) | Main stage catheterization instrument | |
US20020100482A1 (en) | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |